Literature DB >> 15668790

Expression pattern of apoptosis-related markers in Huntington's disease.

José C Vis1, Ellis Schipper, Roelie T de Boer-van Huizen, Marcel M Verbeek, Rob M W de Waal, Pieter Wesseling, Hans J ten Donkelaar, Berry Kremer.   

Abstract

Inappropriate apoptosis has been implicated in the mechanism of neuronal death in Huntington's disease (HD). In this study, we report the expression of apoptotic markers in HD caudate nucleus (grades 1-4) and compare this with controls without neurological disease. Terminal transferase-mediated biotinylated-UTP nick end-labeling (TUNEL)-positive cells were detected in both control and HD brains. However, typical apoptotic cells were present only in HD, especially in grade 3 and 4 specimens. Expression of the pro-apoptotic protein Bax was increased in HD brains compared to controls, demonstrating a cytoplasmic expression pattern in predominantly shrunken and dark neurons, which were most frequently seen in grades 2 and 3. Control brains displayed weak perinuclear expression of the anti-apoptotic protein Bcl-2, whereas in HD brains Bcl-2 immunoreactivity was markedly enhanced, especially in severely affected grade 4 brains, and was observed in both healthy neurons and dark neurons. Caspase-3, an executioner protease, was only found in four HD brains of different grades and was not expressed in controls. A strong neuronal and glial expression of poly(ADP-ribose) polymerase (PARP)-immunoreactivity was observed in HD brains. These data strongly suggest the involvement of apoptosis in HD. The exact apoptotic pathway occurring in HD neurodegeneration remains yet unclear. However, the presence of late apoptotic events, such as enhanced PARP expression and many TUNEL-positive cells accompanied with weak caspase-3 immunoreactivity in severely affected HD brains, suggests that caspase-mediated neuronal death only plays a minor role in HD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668790     DOI: 10.1007/s00401-004-0957-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  31 in total

1.  Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells.

Authors:  Ferdinando Squitieri; Vittorio Maglione; Sara Orobello; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2011-04-26       Impact factor: 3.575

Review 2.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 3.  Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.

Authors:  Amos A Fatokun; Valina L Dawson; Ted M Dawson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 4.  Potential future neuroprotective therapies for neurodegenerative disorders and stroke.

Authors:  Rawan Tarawneh; James E Galvin
Journal:  Clin Geriatr Med       Date:  2010-02       Impact factor: 3.076

5.  Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.

Authors:  Sarumani Natarajan Suganya; Thangarajan Sumathi
Journal:  Metab Brain Dis       Date:  2016-12-08       Impact factor: 3.584

Review 6.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

Review 7.  PARP overactivation in neurological disorders.

Authors:  Vijay Kumar Arruri; Chayanika Gundu; Islauddin Khan; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Mol Biol Rep       Date:  2021-03-25       Impact factor: 2.316

Review 8.  Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration.

Authors:  Mariana Pehar; Benjamin A Harlan; Kelby M Killoy; Marcelo R Vargas
Journal:  Antioxid Redox Signal       Date:  2017-06-27       Impact factor: 8.401

9.  Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs.

Authors:  Dongshan Yang; Chuan-En Wang; Bentian Zhao; Wei Li; Zhen Ouyang; Zhaoming Liu; Huaqiang Yang; Pei Fan; Ashley O'Neill; Weiwang Gu; Hong Yi; Shihua Li; Liangxue Lai; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2010-07-21       Impact factor: 6.150

10.  Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range.

Authors:  Pritha Majumder; Swasti Raychaudhuri; Biswanath Chattopadhyay; Nitai P Bhattacharyya
Journal:  Cell Mol Neurobiol       Date:  2007-09-28       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.